Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 2/26/2021NMPA Announces Package Insert Revision of Misoprostol Tablets
  • 2/25/2021CDE Seeks Comments on Implementation Advice on ICH Guidelines Q5D, M9 ...
  • 2/25/2021CDE Issues the Technical Guidelines for Non-clinical Studies of Radioa...
  • 2/24/2021Review of Chinese Import Chemical Drug IND Applications in 2020
  • 2/23/2021NMPA Solicits Comments on the Draft Technical Guidelines for Non-clini...
  • 2/23/2021CDE Issues New Guideline Document for Publication of Technical Evaluat...
  • 2/23/2021NMPA Issues the List of Reference Formulations for GQCE Studies (38th ...
  • 2/20/2021Three Central Government Agencies Issue the Guidelines for Integrity o...
  • 2/20/2021CDE Solicits Comments on the Technical Requirements for Pharmaceutical...
  • 2/17/2021CDE Issues the Technical Guidelines for Similarity Assessment and Indi...
  • 2/10/2021CDE Issues Three Documents for Change Filings of Chemical Drugs and Bi...
  • 2/9/2021CDE Issues the Technical Guidelines for Clinical Testing of Immune Cel...
  • 2/9/2021CDE Issues the Technical Guidelines for Clinical Trial of Human Immuno...
  • 2/9/2021CDE Issues the Technical Guidelines for Research of Generic Fulvestran...
  • 2/9/2021NMPA Issues the Announcement on Post-Marketing Drug Changes and Dosser...
  • 2/9/2021CDE Issues the Technical Guidelines for Clinical Study Protocol Design...
  • 2/9/2021CDE Issues the Technical Guidelines for Clinical Study of Complicated ...
  • 2/9/2021CDE Solicits Comments on the Technical Guidelines for Non-clinical Res...
  • 2/9/2021NMPA Adds 72 Designated Core Laboratories to Support MedPharm Regulati...
  • 2/9/2021NMPA Revises Packages Inserts of Thiamazole Formulations
  • 2/8/2021CDE Issues the Technical Guidelines for Clinical Pharmacokinetics of T...
  • 2/5/2021NMPA Holds National Drug Registration and Post Marketing Regulation Co...
  • 2/4/2021CDE Issues the Technical Guidelines for Clinical Trial of Omalizumab B...
  • 2/3/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (4...
  • 2/1/2021China Unveils Action Plan on Building High-Standard Market System with...
  • 2/1/2021CDE Issues the Technical Guidelines for Clinical Trials of Therapeutic...
  • 1/29/2021NMPA Holds National Drug Regulatory Conference, Highlighting Path Forw...
  • 1/29/2021CDE Issues the Guideline on Adaptive Designs for Clinical Trials
  • 1/27/2021CDE Solicits Comments on Two Technical Documents for Pharmaceutical St...
  • 1/26/2021CDE Issues the Technical Guidelines for Drug Interaction Research
  • Page:1/10 Total number of articles:289: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group